Mark Schoenberg - Jan 20, 2023 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)

Role
Chief Medical Officer
Signature
/s/ Jason D. Smith, Attorney-in-Fact
Stock symbol
URGN
Transactions as of
Jan 20, 2023
Transactions value $
$613,385
Form type
4
Date filed
1/23/2023, 06:10 PM
Previous filing
Nov 2, 2022
Next filing
Feb 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Options Exercise $613K +123K +512.22% $5.00* 147K Jan 20, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction URGN Employee Stock Option (right to buy) Options Exercise $0 -123K -100% $0.00* 0 Jan 20, 2023 Ordinary Shares 123K $5.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.